EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

This list contains a non-exhaustive inventory of substances that fall within the scope of the European Union's definition of hazardous chemical and biological substances, as provided on: (1) Table 3 of Annex VI to the CLP Regulation 1272/2008/EC; and (2) Annex III of Directive 2000/54/EC (Biological Agents). The EU's Occupational Safety and Health (OSH) Framework Directive 89/391/EEC applies to risks arising from chemical, physical and biological agents at the workplace.

Last updated 26 aprile 2024. Database contains 4691 unique substances/entries.

Filter the list

Mostrati 3.601 - 3.800 su 4.691 risultati.

Substance Name	EC No.	CAS No.	EU CLP (1272/2008)
valinamide D,L-VALINEAMIDE	402-840-7	20108-78-5	Repr. 2; Eye Irrit. 2; Skin Sens. 1
1,2,5,6,9,10-hexabromocyclododecane	221-695-9	3194-55-6	Repr. 2; Lact.
fenarimol (ISO); 2,4'-dichloro-α-(pyrimidin-5-yl)benzhydryl alcohol	262-095-7	60168-88-9	Repr. 2; Lact.
hexabromocyclododecane show/hide gamma-hexabromocyclododecane EC / List no: 603-804-5 \| CAS no: 134237-52-8 beta-hexabromocyclododecane EC / List no: 603-802-4 \| CAS no: 134237-51-7 1,2,5,6,9,10-hexabromocyclodecane EC / List no: 221-695-9 \| CAS no: 3194-55-6 alpha-hexabromocyclododecane EC / List no: 603-801-9 \| CAS no: 134237-50-6 Hexabromocyclododecane EC / List no: 247-148-4 \| CAS no: 25637-99-4	247-148-4	25637-99-4	Repr. 2; Lact.
metaflumizone (ISO); (E)-2-[2-(4-cyanophenyl)-1-(a,a,a -trifluoro-m-tolyl) ethylidene]-[4-(trifluoro-methoxy)phenyl]carbani-lohydrazide [2]	701-454-9	852403-68-0	Repr. 2; Lact.; STOT RE 2
metaflumizone (ISO); (EZ)-2-[2-(4-cyanophe-nyl)-1-(a,a,a -trifluoro-m-tolyl)ethylidene]-[4-(tri-fluoromethoxy)phenyl] carbanilohydrazide [E-iso-mer > 90 %, Z-isomer <10 % relative content]	604-167-6	139968-49-3	Repr. 2; Lact.; STOT RE 2
(R)-5-bromo-3-(1-methyl-2-pyrrolidinyl methyl)-1H-indole UK-111,975	422-390-5	143322-57-0	Repr. 2; STOT RE 1; Acute Tox. 4; Skin Sens. 1
amitrole (ISO);1,2,4-triazol-3-ylamine	200-521-5	61-82-5	Repr. 2; STOT RE 2
mesotrione(ISO); 2-[4-(methylsulfonyl)-2-nitrobenzoyl]-1,3-cyclohexanedione	600-533-4	104206-82-8	Repr. 2; STOT RE 2
oxadiargyl (ISO); 3-[2,4-dichloro-5-(2-propynyloxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one	254-637-6	39807-15-3	Repr. 2; STOT RE 2
triammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate	432-270-4	221354-37-6	Repr. 2; STOT RE 2
triticonazole (ISO); (RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol	-	138182-18-0	Repr. 2; STOT RE 2
2-(4-tert-butylphenyl)ethanol TBPE	410-020-5	5406-86-0	Repr. 2; STOT RE 2; Eye Dam. 1
(R, S)-2-amino-3,3-dimethylbutane amide	447-860-7	144177-62-8	Repr. 2; STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
dodemorph (ISO); 4-cyclododecyl-2,6-dimethylmorpholine	216-474-9	1593-77-7	Repr. 2; STOT RE 2; Skin Corr. 1C; Skin Sens. 1A
dodemorph acetate; 4-cyclododecyl-2,6-dimethylmorpholin- 4-ium acetate	250-778-2	31717-87-0	Repr. 2; STOT RE 2; Skin Corr. 1C; Skin Sens. 1A
(S)-2,3-dihydro-1H-indole-2-carboxylic acid [S]-2-INDOLINE CARBOXYLIC ACID	410-860-2	79815-20-6	Repr. 2; STOT RE 2; Skin Sens. 1
tembotrione (ISO); 2-{2- chloro-4-(methylsulfonyl)-3- [(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione	608-879-8	335104-84-2	Repr. 2; STOT RE 2; Skin Sens. 1
sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3-dione	619-394-6	99105-77-8	Repr. 2; STOT RE 2; Skin Sens. 1A
spirotetramat (ISO); (5s,8s)-3- (2,5-dimethylphenyl)-8-methoxy-2-oxo-1-azaspiro[4,5]dec- 3-en-4-yl ethyl carbonate	606-523-6	203313-25-1	Repr. 2; STOT SE 3; Eye Irrit. 2; Skin Sens. 1A
piperazine [liquid];piperazine [solid]	203-808-3	110-85-0	Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
piperazine [liquid];piperazine [solid]	203-808-3	110-85-0	Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1
4-tert-butylphenol	202-679-0	98-54-4	Repr. 2; Skin Irrit. 2; Eye Dam. 1
silver zinc zeolite (Zeolite, LTA framework type, surface-modified with silver and zinc ions)	603-404-0	130328-20-0	Repr. 2; Skin Irrit. 2; Eye Dam. 1
benzyl 2,4-dibromobutanoate B2,4DBB	420-710-8	23085-60-1	Repr. 2; Skin Irrit. 2; Skin Sens. 1
reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol; 5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol	427-050-1	170016-25-8	Repr. 2; Skin Irrit. 2; Skin Sens. 1
4,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol	428-970-4	13595-25-0	Repr. 2; Skin Sens. 1
Margosa, ext. [from the kernels of Azadirachta indica extracted with water and further processed with organic solvents] Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Azadirachta indica, Meliaceae.	283-644-7	84696-25-3	Repr. 2; Skin Sens. 1
N-[2-(3-acetyl-5-nitrothiophen-2-ylazo)-5-diethylaminophenyl]acetamide DISPERSOL BLUE C-4G COLOUR; SUBSTANCE H87919	416-860-9	777891-21-1	Repr. 2; Skin Sens. 1
reaction mass of: Ca salicylates (branched C10-14 and C18-30 alkylated); Ca phenates (branched C10-14 and C18-30 alkylated); Ca sulfurised phenates(branched C10-14 and C18-30 alkylated) SP 7053	415-930-6	-	Repr. 2; Skin Sens. 1
trans-4-phenyl-L-proline SQ 27,616	416-020-1	96314-26-0	Repr. 2; Skin Sens. 1
(1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate P-NITROBENZYLESTER PGSO	412-670-5	54275-93-3	Resp. Sens. 1
(1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate G-EXOMETHYLENE SULFOXIDE ESTER	412-800-0	76109-32-5	Resp. Sens. 1
amylase, α-	232-565-6	9000-90-2	Resp. Sens. 1
amylases with the exception of those specified elsewhere in this Annex show/hide Amylase, fungal EC / List no: 232-742-8 \| CAS no: 9013-01-8 Amylase, gluco- EC / List no: 232-877-2 \| CAS no: 9032-08-0 Amylase, gluco-, Rhizopus oryzae EC / List no: - \| CAS no: 152923-55-2 Amylase, α- EC / List no: 232-565-6 \| CAS no: 9000-90-2 Amylase, alpha-, Bacillus amyloliquefaciens EC / List no: - \| CAS no: 152923-48-3 Amylase, iso- EC / List no: 232-956-1 \| CAS no: 9067-73-6 Amylase EC / List no: 232-567-7 \| CAS no: 9000-92-4 Amylase, β- EC / List no: 232-566-1 \| CAS no: 9000-91-3 Amylase, bacterial EC / List no: 232-560-9 \| CAS no: 9000-85-5 Amylase, mixed with proteinase, Bacillus thuringiensis-fermented EC / List no: - \| CAS no: 68909-36-4 Bacteria, complex with amylase and proteinase EC / List no: - \| CAS no: 68920-42-3 Amylase, α-, Aspergillus oryzae EC / List no: 232-588-1 \| CAS no: 9001-19-8 Amylase, mixture with proteinase EC / List no: 685-079-5 \| CAS no: 9001-11-0 Amylase, mixed with proteinase, Bacillus cereus-fermented EC / List no: - \| CAS no: 68909-35-3	-	-	Resp. Sens. 1
C,C'-azodi(formamide)	204-650-8	123-77-3	Resp. Sens. 1
cellobiohydrolase, exo-	253-465-9	37329-65-0	Resp. Sens. 1
cellulase	232-734-4	9012-54-8	Resp. Sens. 1
cellulases with the exception of those specified elsewhere in this Annex	-	-	Resp. Sens. 1
glucosidase, β-	232-589-7	9001-22-3	Resp. Sens. 1
laccase SP 807	420-150-4	80498-15-3	Resp. Sens. 1
tetrasodium 5-(4,6-dichloro-5-cyanopyrimidin-2-ylamino)-4-hydroxy-2,3-azodinaphthalene-1,2,5,7-disulphonate C.I. REACTIVE RED 219	400-130-1	149057-72-7	Resp. Sens. 1
2,4,6-triisopropyl-m-phenylene diisocyanate	218-485-4	2162-73-4	Resp. Sens. 1; Skin Sens. 1
4,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)	420-530-1	177027-34-8	Resp. Sens. 1; Skin Sens. 1
7-amino-3-((5-carboxymethyl-4- methyl-1,3-thiazol-2- ylthio)methyl)-8-oxo-5-thia-1- azabicyclo(4.2.0)oct-2-ene-2- carboxylic acid TACS	403-690-5	111298-82-9	Resp. Sens. 1; Skin Sens. 1
hexasodium 6,13-dichloro-3,10- bis((4-(2,5-disulfonatoanilino)-6- fluoro-1,3,5-triazin-2- ylamino)prop-3-ylamino)-5,12- dioxa-7,14-diazapentacene-4,11- disulfonate C.I. BLEU REACTIF 204; C.I. REACTIVE BLUE 204; REACTIVE BLUE 204; REAKTIV BLAU 204	400-050-7	85153-92-0	Resp. Sens. 1; Skin Sens. 1
tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate 3-BMC	407-620-4	33610-13-8	Resp. Sens. 1; Skin Sens. 1
1,3-bis(1-isocyanato-1-methylethyl)benzene; [m-TMXDI]	220-474-4	2778-42-9	Resp. Sens. 1; Skin Sens. 1A
1,3-bis(isocyanatomethyl)benzene; [m-XDI]	222-852-4	3634-83-1	Resp. Sens. 1; Skin Sens. 1A
dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one)	200-632-9	66-76-2	STOT RE 1; Acute Tox. 4
N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide	423-530-8	152828-23-4	STOT RE 1; Acute Tox. 4
tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate	428-070-1	91788-83-9	STOT RE 1; Acute Tox. 4
trisodium hexafluoroaluminate	237-410-6	13775-53-6	STOT RE 1; Acute Tox. 4
trisodium hexafluoroaluminate(cryolite)	239-148-8	15096-52-3	STOT RE 1; Acute Tox. 4
1-aminocyclopentanecarboxamide	422-950-9	17193-28-1	STOT RE 1; Acute Tox. 4; Eye Dam. 1
(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride	426-200-1	172015-79-1	STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
dibenzylphenylsulfonium hexafluoroantimonate ZK RT 1507	417-760-8	134164-24-2	STOT RE 1; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
5,5-dimethyl-perhydro-pyrimidin-2-one α-(4-trifluoromethylstyryl)-α-(4-trifluoromethyl)cinnamylidenehydrazone HYDRAMETHYLNON	405-090-9	67485-29-4	STOT RE 1; Acute Tox. 4; Eye Irrit. 2
4-(2-chloro-4-trifluoromethyl)phenoxy-2-fluoroaniline hydrochloride WL 125892	402-190-4	113674-95-6	STOT RE 1; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
reaction mass of: tri-p-tolyltin hydroxide; hexa-p-tolyl-distannoxane	432-230-6	-	STOT RE 1; Acute Tox. 4; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
2-nitro-2-phenyl-1,3-propanediol 2-NPP	410-360-4	5428-02-4	STOT RE 1; Acute Tox. 4; Skin Sens. 1
solvent naphtha (petroleum), medium aliph.; Straight run kerosine [A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140°C to 220°C (284°F to 428°F).] A complex combination of hydrocarbons obtained from the distillation of crude oil or natural gasoline. It consists predominantly of saturated hydrocarbons having carbon numbers predominantly in the range of C9 through C12 and boiling in the range of approximately 140°C to 220°C (284°F to 428°F).	265-191-7	64742-88-7	STOT RE 1; Asp. Tox. 1
trioctylstannane TZ 02508	413-320-4	869-59-0	STOT RE 1; Skin Irrit. 2
benzoic acid	200-618-2	65-85-0	STOT RE 1; Skin Irrit. 2; Eye Dam. 1
reaction mass of: 2-[N-ethyl-4-[(5,6-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate; 2-[N-ethyl-4-[(6,7-dichlorobenzothiazol-2-yl)azo]-m-toludino]ethyl acetate (1:1) RED E190	411-560-4	-	STOT RE 1; Skin Sens. 1
reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane DOW CORNING (R) 4-2920 INTERMEDIATE	406-930-7	96-29-7	STOT RE 1; Skin Sens. 1
(3-aminophenyl)pyridin-3-ylmethanone	428-230-0	79568-06-2	STOT RE 2
1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione	421-080-7	161462-35-7	STOT RE 2
2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one	434-820-9	106461-41-0	STOT RE 2
2-(3-chloropropyl)-2,5,5-trimethyl-1,3-dioxane 5-CHLOR-2-PENTANON-NEOPENTYLKETAL; 5-CHLORO-2-PENTANONE-NEOPENTYLKETAL; CHLORKETAL	417-650-1	88128-57-8	STOT RE 2
2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one	444-860-9	474510-57-1	STOT RE 2
3'-trifluoromethylisobutyranilide BTA-A; FLUTAMIDE BTA-A	406-740-4	1939-27-1	STOT RE 2
3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluorooctan-1-ol	211-477-1	647-42-7	STOT RE 2
3-acetyl-1-phenyl-pyrrolidine-2,4-dione ADDITIVE F6	421-600-2	719-86-8	STOT RE 2
4,4'-methylenebis(2-isopropyl-6-methylaniline) LONZACURE M-MIPA	415-150-6	16298-38-7	STOT RE 2
4-(4-tolyloxy)biphenyl JKY-120	405-730-7	51601-57-1	STOT RE 2
coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin	201-378-1	81-82-3	STOT RE 2
famoxadone (ISO); 3-anilino-5-methyl-5-(4-phenoxyphenyl)-1,3-oxazolidine-2,4-dione	603-520-1	131807-57-3	STOT RE 2
magnesium sodium fluoride silicate	442-650-1	56450-90-9	STOT RE 2
manganese sulphate	232-089-9	7785-87-7	STOT RE 2
methyl 3-amino-4,6-dibromo-2-methyl-benzoate	425-190-6	119916-05-1	STOT RE 2
N-[4-cyano-3-trifluoromethylphenyl]methacrylamide	427-880-2	90357-53-2	STOT RE 2
oxasulfuron (ISO); oxetan-3-yl 2-[(4,6-dimethylpyrimidin-2-yl)-carbamoylsulfamoyl]benzoate	604-430-5	144651-06-9	STOT RE 2
picolinafen (ISO); N-(4-fluorophenyl)-6-[3-(trifluoromethyl)phenoxy] pyridine-2-carboxamide; 4′-fluoro-6-[(α,α,α-trifluoro-m-tolyl) oxy]picolinanilide	604-030-0	137641-05-5	STOT RE 2
polychlorobiphenyls; PCB	215-648-1	1336-36-3	STOT RE 2
Reaction mass of: 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-tridecafluorooctyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heptdecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-tridecafluorooctyl)-12-(1''H,1''H,2''H,2''H-pentacosafluorotetradecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heptadecafluorodecyl)dodecanedioate; 1-(1'H,1'H,2'H,2'H-heptadecafluorodecyl)-12-(1''H,1''H,2''H,2''H-heneicosafluorododecyl)dodecanedioate HFR-990	423-180-6	-	STOT RE 2
reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N, N',O, O'-copper complex;2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N, N',O, O'-copper complex	419-610-7	171866-24-3	STOT RE 2
reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate ACRYLSKUM; T-2816 FOAMER	407-810-7	-	STOT RE 2
reaction mass of: 5-(N-methylperfluorooctylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one; 5-(N-methylperfluoroheptylsulfonamido)methyl-3-octadecyl-1,3-oxazolidin-2-one T-4240 FLUOROCHEMICAL URETHANE DERIVATIVE	413-640-4	-	STOT RE 2
reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane; bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide; bis(1-phenyl-1,3-decanedionyl)dioctyl stannane; ((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane	422-920-5	-	STOT RE 2
reaction mass of: N-(3-dimethylamino-4-methyl-phenyl)-benzamide; N-(3-dimethylamino-2-methyl-phenyl)-benzamide; N-(3-dimethylamino-3-methyl-phenyl)-benzamide PERGASCRIPT BLACK 20223 AMIDE INTERMEDIATE	420-600-1	-	STOT RE 2
reaction mass of: O, O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)	423-580-0	-	STOT RE 2
reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate; N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane; sulfonamide	422-500-1	-	STOT RE 2
reaction mass of:[2-(anthraquinon-1-ylamino)-6-[(5-benzoylamino)-anthraquinone-1-ylamino]-4-phenyl]-1,3,5-triazine; 2,6-bis-[(5-benzoylamino)-anthraquinon-1-ylamino]-4-phenyl-1,3,5-triazine. ORANGE LEP 2471	421-290-9	-	STOT RE 2
silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, hydrolysis products with silica; pyrogenic, synthetic amorphous, nano, surface treated silicon dioxide	272-697-1	68909-20-6	STOT RE 2
silthiofam (ISO); N-allyl-4,5-dimethyl-2-(trimethylsilyl)thiophene-3-carboxamide	605-752-9	175217-20-6	STOT RE 2
tetradecylammonium bis(1-(5-chloro-2-oxidophenylazo)-2-naphtholato)chromate(1-) KAYASET BLACK T-2	405-110-6	88377-66-6	STOT RE 2
2S-isopropyl-5R-methyl-1R-cyclohexyl 2,2-dihydroxyacetate GLYOXYLATE DE MENTHYLE HYDRATÉ; MENTHYL GLYOXYLATE HYDRATE	416-810-6	111969-64-3	STOT RE 2; Eye Dam. 1
bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate	421-560-6	-	STOT RE 2; Eye Dam. 1
reaction mass of: bis(1S,2S,4S)-(1-benzyl-4-tert-butoxycarboxamido-2-hydroxy-5-phenyl)pentylammonium succinate; isopropyl alcohol A-88820.605	414-810-0	-	STOT RE 2; Eye Dam. 1
((4-phenylbutyl)hydroxyphosphoryl)acetic acid SQ 26999	412-170-7	83623-61-4	STOT RE 2; Eye Dam. 1; Skin Sens. 1
(2R,3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride	425-260-6	244634-31-9	STOT RE 2; Eye Dam. 1; Skin Sens. 1
1,3-bis(3-methyl-2,5-dioxo-1H-pyrrolinylmethyl)benzene PERKALINK 900	412-570-1	119462-56-5	STOT RE 2; Eye Dam. 1; Skin Sens. 1
2,5-dioxopyrrolidin-1-yl N-{[methyl[[2-(1-methylethyl)-4-thiazoly]methyl]amino]carbonyl}-L-Valinate	424-660-8	-	STOT RE 2; Eye Dam. 1; Skin Sens. 1
bis(N-(7-hydroxy-8-methyl-5-phenylphenazin-3-ylidene)dimethylammonium) sulfate SAFRANIN SHMN	406-770-8	149057-64-7	STOT RE 2; Eye Dam. 1; Skin Sens. 1
dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate; (5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate AMINODARONE OXALATE; SR33580A	448-700-9	500791-70-8	STOT RE 2; Eye Dam. 1; Skin Sens. 1
potassium N-(4-fluorophenyl)glycinate POTASSIUM N-(4-FLUOROPHENYL)GLYCINATE	415-710-1	184637-63-6	STOT RE 2; Eye Dam. 1; Skin Sens. 1
3-tridecyloxy-propyl-ammonium 9-octadecenoate Z-29	418-990-1	778577-53-0	STOT RE 2; Eye Irrit. 2; Skin Irrit. 2
4-(4-nitrophenylazo)-2,6-di-sec-butyl-phenol MORTRACE SB CONC.	410-610-2	111850-24-9	STOT RE 2; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1
diphenyl ether, pentabromo derivative pentabromodiphenyl ether	251-084-2	32534-81-9	STOT RE 2; Lact.
methyl 3-isocyanatosulfonyl-2-thiophene-carboxylate F7641; MTSI	410-550-7	79277-18-2	STOT RE 2; Resp. Sens. 1; Skin Sens. 1
4-(3,4-dichlorophenylazo)-2,6-di-sec-butyl-phenol MORTRACE ST CONC.	410-600-8	124719-26-2	STOT RE 2; Skin Irrit. 2
2-(decylthio)ethylammonium chloride XU 40304.03L ANTIMICROBIAL	405-640-8	36362-09-1	STOT RE 2; Skin Irrit. 2; Eye Dam. 1
2-n-hexadecylhydroquinone AF-368	406-400-5	4595-26-0	STOT RE 2; Skin Irrit. 2; Skin Sens. 1
(2,4-diaminopteridin-6-yl)methanol hydrobromide	430-620-0	76145-91-0	STOT RE 2; Skin Sens. 1
2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al C25-ALDEHYD	415-770-7	1638-05-7	STOT RE 2; Skin Sens. 1
2-((4-(ethyl-(2-hydroxyethyl)amino)-2-methylphenyl)azo)-6-methoxy-3-methyl-benzothiazolium methylsulfate FAT 40'398; FAT 40'398/E	411-100-2	136213-73-5	STOT RE 2; Skin Sens. 1
2-butanone-O, O',O''-(phenylsilylidyne)trioxime	433-360-6	34036-80-1	STOT RE 2; Skin Sens. 1
2-chloro-4-fluoro-5-nitrophenyl(isobutyl)carbonate	427-020-6	141772-37-4	STOT RE 2; Skin Sens. 1
2-naphthylamino-6-sulfomethylamide 2-NAPHTHYLAMIN-6-SULFOMETHYLAMID; FAT 92'365/A	412-120-4	104295-55-8	STOT RE 2; Skin Sens. 1
4-(2-cyano-3-phenylamino acryloyloxymethyl)-cyclohexyl-methyl 2-cyano-3-phenylamino)-acrylate LICHTSCHUTZMITTEL 1071	413-510-7	147374-67-2	STOT RE 2; Skin Sens. 1
atrazine (ISO);2-chloro-4-ethylamine-6- isopropylamine-1,3,5-triazine	217-617-8	1912-24-9	STOT RE 2; Skin Sens. 1
bifenazate (ISO); isopropyl 2-(4-methoxybiphenyl-3-yl)hydrazinecarboxylate	442-820-5	149877-41-8	STOT RE 2; Skin Sens. 1
bromobenzylbromotoluene, reaction mass of isomers DBBT	402-210-1	99688-47-8	STOT RE 2; Skin Sens. 1
carboxin (ISO); 2-methyl-N-phenyl-5,6-dihydro-1,4-oxathiine-3-carboxamide; 5,6-dihydro-2-methyl-1,4-oxathiine-3-carboxanilide	226-031-1	5234-68-4	STOT RE 2; Skin Sens. 1
ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate	429-020-1	204254-96-6	STOT RE 2; Skin Sens. 1
fenoxaprop-P-ethyl (ISO); ethyl (2R)-2-{4-[(6-chloro-1,3-benzoxazol-2-yl)oxy]phenoxy}propanoate	615-273-7	71283-80-2	STOT RE 2; Skin Sens. 1
N, N-dimethyl-2-(3-(4-chloro phenyl)-4,5-dihydropyrazol-1- ylphenylsulphonyl)ethylamine HOSTALUX VP 3481	401-410-6	10357-99-0	STOT RE 2; Skin Sens. 1
reaction mass of 7-[4-(3-diethylaminopropylamino)-6-(3-diethylammoniopropylamino)-1,3,5-triazin-2-ylamino]-4-hydroxy-3-(4-phenylazophenylazo)-naphthalene-2-sulfonate, acetic acid, lactic acid (2:1:1) CARTASOL RED K-2BN; RED 10 25 501	408-000-6	118658-98-3	STOT RE 2; Skin Sens. 1
tribenuron-methyl (ISO); 2-[4-methoxy-6-methyl-1,3,5-triazin-2-yl(methyl)carbamoylsulfamoyl]benzoic acid methyl ester; methyl 2-(3-(4-methoxy-6-methyl-1,3,5-triazin-2-yl)-3methylureidosulfonyl)benzoate	401-190-1	101200-48-0	STOT RE 2; Skin Sens. 1
trinexapac-ethyl (ISO); ethyl 4-[cyclopropyl (hydroxy) methylene]-3,5-dioxocyclohexanecarboxylate	680-302-2	95266-40-3	STOT RE 2; Skin Sens. 1B
mipafox (ISO); N,N'-di-isopropylphosphorodiamidic fluoride	206-742-3	371-86-8	STOT SE 1
tricresyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-); tritolyl phosphate (m-m-m-, m-m-p-, m-p-p-, p-p-p-);tricresyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-); tritolyl phosphate (o-o-o-, o-o-m-, o-o-p-, o-m-m-, o-m-p-, o-p-p-)	215-548-8	1330-78-5	STOT SE 1
4-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt	426-900-7	203118-12-1	STOT SE 3
dodecyl methacrylate	205-570-6	142-90-5	STOT SE 3
TCA-sodium (ISO); sodium trichloroacetate	211-479-2	650-51-1	STOT SE 3
benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride	209-008-0	552-30-7	STOT SE 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1
piperonyl butoxide (ISO); 2-(2-butoxyethoxy)ethyl 6-propylpiperonyl ether	200-076-7	51-03-6	STOT SE 3; Eye Irrit. 2
cyclohexyl acrylate	221-319-3	3066-71-5	STOT SE 3; Skin Irrit. 2
poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]	427-480-8	176429-22-4	STOT SE 3; Skin Irrit. 2; Eye Dam. 1
poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]	427-280-0	176429-27-9	STOT SE 3; Skin Irrit. 2; Eye Dam. 1
reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)	432-200-2	1379679-02-3	STOT SE 3; Skin Irrit. 2; Eye Dam. 1
subtilisin	232-752-2	9014-01-1	STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1
2,4-dichloro-5-fluorobenzoylchloride	428-390-1	86393-34-2	STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1
1,5-naphthylene diisocyanate [containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm];1,5-naphthylene diisocyanate [containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]	221-641-4	3173-72-6	STOT SE 3; Skin Irrit. 2; Eye Irrit. 2; Resp. Sens. 1; Skin Sens. 1A
2-ethylhexyl acrylate	203-080-7	103-11-7	STOT SE 3; Skin Irrit. 2; Skin Sens. 1
ethylene dimethacrylate	202-617-2	97-90-5	STOT SE 3; Skin Sens. 1
zineb (ISO); zinc ethylenebis(dithiocarbamate) (polymeric)	235-180-1	12122-67-7	STOT SE 3; Skin Sens. 1
zirconium powder (pyrophoric);zirconium powder, dry (non pyrophoric)	231-176-9	7440-67-7	Self-heat. 1
sodium dithionite; sodium hydrosulphite	231-890-0	7775-14-6	Self-heat. 1; Acute Tox. 4
lithium methanolate; lithium methoxide	212-737-7	865-34-9	Self-heat. 1; Skin Corr. 1B
potassium ethanolate; potassium ethoxide	213-029-0	917-58-8	Self-heat. 1; Skin Corr. 1B
potassium methanolate; potassium methoxide	212-736-1	865-33-8	Self-heat. 1; Skin Corr. 1B
sodium ethanolate; sodium ethoxide	205-487-5	141-52-6	Self-heat. 1; Skin Corr. 1B
sodium methanolate; sodium methoxide	204-699-5	124-41-4	Self-heat. 1; Skin Corr. 1B
potassium iron(III) 1,3-propanediamine-N, N,N',N'-tetraacetate hemihydrate FEKPDTA; KFEPDTA	405-680-6	148434-01-9	Self-heat. 2
2,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate	444-250-2	144111-81-9	Self-react. C
ammonium bis(1-(3,5-dinitro-2-oxidophenylazo)-3-(N-phenylcarbamoyl)-2-naphtholato)chromate(1-) AIZEN SPILON BLACK TRH; AIZEN SPILON SCHWARZ TRH; THR-1; TRH	400-110-2	109125-51-1	Self-react. C
reaction mass of esters of 5,5',6,6',7,7'-hexahydroxy-3,3,3',3'-tetramethyl-1,1'-spirobiindan and 2-diazo-1,2-dihydro-1-oxo-5-sulfonaphthalene PS-6 SENSITIZER	413-840-1	121870-66-4	Self-react. C
4-dimethylaminobenzenediazonium 3-carboxy-4-hydroxybenzenesulfonate DIAZO-A-SALICYLSULFONATE	404-980-4	124737-31-1	Self-react. C; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Dam. 1; Skin Sens. 1
2,2'-dimethyl-2,2'-azodipropiononitrile; ADZN	201-132-3	78-67-1	Self-react. C; Acute Tox. 4
2,5-dibutoxy-4-(morpholin-4-yl)benzenediazonium 4-methylbenzenesulfonate DIAZO W 6623-TS	413-290-2	93672-52-7	Self-react. C; Acute Tox. 4; Eye Dam. 1; Skin Sens. 1
R—2,3-epoxy-1-propanol R-GLYCIDOL	404-660-4	57044-25-4	Self-react. C; Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 4; Skin Corr. 1B
6,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)	441-550-5	-	Self-react. C; Carc. 2
reaction mass of: 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinol-4-yl-tris(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate); 4-(7-hydroxy-2,4,4-trimethyl-2-chromanyl)resorcinolbis(6-diazo-5,6-dihydro-5-oxonaphthalen-1-sulfonate) (2:1) T-69	414-770-4	140698-96-0	Self-react. C; Carc. 2
reaction mass of: reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:2); reaction product of 4,4'-methylenebis[2-(4-hydroxybenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxo-naphthalenesulfonate (1:3) T-271	417-980-4	157321-59-0	Self-react. C; Carc. 2
reaction mass of: triammonium; 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate; diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate	438-310-7	-	Self-react. C; Repr. 2; Acute Tox. 4; STOT RE 2
3-azidosulfonylbenzoic acid ASB	405-310-3	15980-11-7	Self-react. C; STOT RE 2; Eye Dam. 1; Skin Sens. 1
4,4'-oxydi(benzenesulphonohydrazide)	201-286-1	80-51-3	Self-react. D
toluene-4-sulphonohydrazide	216-407-3	1576-35-8	Self-react. D
reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile; 2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2,2'-dimethyl-2,2'-azoheptanenitrile; 2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile); 2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)	429-710-2	-	Self-react. D; Acute Tox. 4
reaction mass of: 4,4',4''-[(2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,3,5-triyl)tris[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]trisbenzenediazoniumtri[bis(2-methylpropyl)naphthalenesulfonate];4,4',4'',4'''-[[5,5'-[carbonylbis[imino(1,5,5-trimethyl-3,1-cyclohexanediyl)methylene]]-2,4,6-trioxo-1,3,5(2H,4H,6H)-triazine-1,1',3,3'-tetrayl]tetrakis[methylene(3,5,5-trimethyl-3,1-cyclohexanediyl)iminocarbonyloxy-2,1-ethanediyl(ethyl)amino]]tetrakisbenzenediazoniumtetra[bis(2-methylpropyl)naphthalenesulfonate] 34 DIAZO	417-080-1	-	Self-react. D; Skin Sens. 1
mecetronium etilsulfate; N-ethyl-N,N-dimethylhexadecan-1-aminium ethyl sulfate; mecetronium ethyl sulphate; [MES]	221-106-5	3006-10-8	Skin Corr. 1; Eye Dam. 1
chloro(3-(3-chloro-4-fluorophenyl)propyl)dimethylsilane SILAN MCS	410-270-5	770722-46-8	Skin Corr. 1A
dichloro-(3-(3-chloro-4-fluorophenyl)propyl)methylsilane SILAN DCS	407-180-3	770722-36-6	Skin Corr. 1A
dichloroacetic acid	201-207-0	79-43-6	Skin Corr. 1A
dichloroacetyl chloride	201-199-9	79-36-7	Skin Corr. 1A
disodium 9,10-anthracenedioxide 9,10-ANTHRACENEDIOL, DISODIUM SALT	426-030-8	46492-07-3	Skin Corr. 1A
formic acid ... %	200-579-1	64-18-6	Skin Corr. 1A
phosphorus pentoxide	215-236-1	1314-56-3	Skin Corr. 1A
platinum(IV) nitrate/nitric acid solution	432-400-1	10102-09-7	Skin Corr. 1A
sodium hydroxide; caustic soda	215-185-5	1310-73-2	Skin Corr. 1A
sulphuric acid ... %	231-639-5	7664-93-9	Skin Corr. 1A
TCA (ISO); trichloroacetic acid	200-927-2	76-03-9	Skin Corr. 1A
3-(4-fluorophenyl)-2-methylpropionylchloride	426-370-7	1017183-70-8	Skin Corr. 1A; Acute Tox. 4
7,7-dimethyl-3-oxa-6-azaoctan-1-ol FLEXSORB-SE	400-390-6	87787-67-5	Skin Corr. 1A; Acute Tox. 4
chlorosulphonic acid	232-234-6	7790-94-5	Skin Corr. 1A; STOT SE 3
oleum ... % SO3	-	-	Skin Corr. 1A; STOT SE 3
[3-(chlorocarbonyl)-2-methylphenyl]acetate	433-690-0	167678-46-8	Skin Corr. 1A; Skin Sens. 1
N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide	431-530-4	1380226-29-8	Skin Corr. 1A; Skin Sens. 1
(1-hydroxydodecylidene)diphosphonic acid KELCOR; LIPOKEL; SEQUOL	425-230-2	16610-63-2	Skin Corr. 1B
(Z)-13-docosenyl-N,N-bis(2-hydroxyethyl)-N-methyl-ammonium-chloride CLEARFRAC J508B	426-210-6	120086-58-0	Skin Corr. 1B
1,1-diisopropoxycyclohexane	413-740-8	1132-95-2	Skin Corr. 1B
1-aminopropan-2-ol; isopropanolamine	201-162-7	78-96-6	Skin Corr. 1B
2,4,6-tri-n-propyl-2,4,6-trioxo-1,3,5,2,4,6-trioxatriphosphorinane T3P	422-210-5	68957-94-8	Skin Corr. 1B
2,4-dichloro-3-ethylphenol PM 9879	401-060-4	121518-45-4	Skin Corr. 1B
2-(1-methylpropyl)-4-tert-butylphenol 2S4TBP	421-740-4	51390-14-8	Skin Corr. 1B
2-chlorobenzaldehyde; o-chlorobenzaldehyde	201-956-3	89-98-5	Skin Corr. 1B
aluminium chloride, anhydrous	231-208-1	7446-70-0	Skin Corr. 1B
ammonia ... %	215-647-6	1336-21-6	Skin Corr. 1B

Mostrati 3.601 - 3.800 su 4.691 risultati.

Export search results to:

EU-SAFETY_HEALTH_WORK-PREAMBLE

EU-SAFETY_HEALTH_WORK-PREAMBLE

Safety and Health of Workers at Work Directive - Hazardous Substances

EU. Hazardous Substances for Purposes of Directive 89/391/EEC, 29 June 1989, amended by Regulation 1137/2008/EC, 21 November 2008 (Table 3/Annex VI, CLP; Annex III, 2000/54/EC)

RELEVANT LEGISLATION

Contact EUCLEF Helpdesk

Last updated 26 aprile 2024. Database contains 4691 unique substances/entries.

Footer Nav Items